STOCK TITAN

Quest Diagnostics Inc. - $DGX STOCK NEWS

Welcome to our dedicated page for Quest Diagnostics news (Ticker: $DGX), a resource for investors and traders seeking the latest updates and insights on Quest Diagnostics stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Quest Diagnostics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Quest Diagnostics's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
none
-
Rhea-AI Summary
Quest Diagnostics: American Heart Association (AHA) honored scholars of its Historically Black Colleges and Universities (HBCU) and Hispanic Serving Institutions (HSI) Scholars Programs with two Spring Research Symposiums. The programs aim to increase the number of African American and Hispanic students in biomedical science, research, and public health programs. Undergraduate students presented their capstone research projects to local leaders and AHA's leadership. Quest for Health Equity supports the program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.22%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.22%
Tags
dividends
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.39%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.3%
Tags
none
Rhea-AI Summary
Quest Diagnostics announces nationwide availability of the RestoreU Dementia Panel, a risk assessment and care plan service created by uMETHOD Health to help physicians improve patient care for cognitive decline.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.85%
Tags
AI
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.97%
Tags
Quest Diagnostics Inc.

NYSE:DGX

DGX Rankings

DGX Stock Data

15.26B
109.71M
0.43%
91.73%
2.29%
Medical Laboratories
Health Care and Social Assistance
Link
United States of America
SECAUCUS

About DGX

quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator